|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07K 14/725 | (2006.01) |
| A61K 38/46 | (2006.01) | ||
| A61K 35/17 | (2015.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C12N 9/22 | (2006.01) | ||
| A61K 35/76 | (2015.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Patento numeris | 3774871 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19721447.1 |
| Europos patento paraiškos padavimo data | 2019-04-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-02-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2019/027019 |
| Data | 2019-04-11 |
| (87) | Numeris | WO 2019/200122 |
| Data | 2019-10-17 |
| (30) | Numeris | Data | Šalis |
| 201862656809 P | 2018-04-12 | US |
| (72) |
SMITH, James, Jefferson , US
LAPE, Janel , US
LI, Hui , US
GENSCHEL, Jochen , US
|
| (73) |
Precision BioSciences, Inc. ,
302 East Pettigrew Street
Dibrell Building, Suite A-100, Durham, NC 27701,
US
|
| (54) | OPTIMIZED ENGINEERED NUCLEASES HAVING SPECIFICITY FOR THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE |
| OPTIMIZED ENGINEERED NUCLEASES HAVING SPECIFICITY FOR THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE |